Kotaro Ogawa

Kotaro Ogawa

Auto-generated profile, based on publicly available information

Kotaro Ogawa

Department of Neurology, Graduate School of Medicine, The University of Osaka, Suita, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
KIKensuke Ikenaka
Kensuke Ikenaka
YKYuta Kajiyama
Yuta Kajiyama
CACésar Aguirre
César Aguirre
CCChi‐Jing Choong
Chi‐Jing Choong
STSeira Taniguchi
Seira Taniguchi
HMHideki Mochizuki
Hideki Mochizuki
The study aims to investigate the vitamin B6 levels in Parkinson's disease (PD) patients and their association with liver enzymes and evaluate how much dysregulation is associated with levodopa dose. Furthermore, to evaluate the effect of Opicapone, a catechol‐o‐methyl‐transferase inhibitor, on vitamin B6 levels by monitoring the AST and ALT levels in patients treated with Levodopa–Carbidopa Intestinal Gel Infusion (LCIG). For these aims, serum vitamin B6 levels were measured (PD, n = 72 and controls, n = 31). The vitamin B6 level was compared with the total levodopa dose, clinical parameters, and blood homocysteine, albumin, and hemoglobin levels in PD patients. Correlations between vitamin B6 levels and AST and ALT levels, as well as the ratio ALT/AST, were analyzed. Changes in the AST and ALT levels and ALT/AST were analyzed in the patients treated with LCIG before and after the therapy (n = 24) and in the patients treated with LCIG + Opicapone before and after Opicapone treatment (n = 12). We found vitamin B6 levels were significantly lower in PD patients. Total levodopa dose and albumin levels were independently associated with vitamin B6 levels. Decreased vitamin B6 levels appeared as lower AST and ALT levels and ALT/AS. Treatment with LCIG decreased the AST and ALT levels and ALT/AST. Adjunctive therapy with Opicapone to LCIG ameliorated the decreased ALT and ALT/AST. We conclude that the ALT and ALT/AST can be useful parameters for monitoring vitamin B6 levels and Opicapone can ameliorate the dysregulated vitamin B6 in PD patients.

18 September 2024 in Movement Disorders
Verified
Journal Article
Open access
STSeira Taniguchi
Seira Taniguchi
YKYuta Kajiyama
Yuta Kajiyama
TKTakanori Kochiyama
Takanori Kochiyama
GRGajanan Revankar
Gajanan Revankar
KOKotaro Ogawa
Kotaro Ogawa
HMHideki Mochizuki
Hideki Mochizuki
Background: Freezing of gait is one of the most disturbing motor symptoms of Parkinson's disease (PD). However, the effective connectivity between key brain hubs that are associated with the pathophysiological mechanism of freezing of gait remains elusive.Objective: The aim of this study was to identify effective connectivity underlying freezing of gait.Methods: This study applied spectral dynamic causal modeling (DCM) of resting‐state functional magnetic resonance imaging in dedicated regions of interest determined using a data‐driven approach.Results: Abnormally increased functional connectivity between the bilateral dorsolateral prefrontal cortex (DLPFC) and the bilateral mesencephalic locomotor region (MLR) was identified in freezers compared with nonfreezers. Subsequently, spectral DCM analysis revealed that increased top‐down excitatory effective connectivity from the left DLPFC to bilateral MLR and an independent self‐inhibitory connectivity within the left DLPFC in freezers versus nonfreezers (>99% posterior probability) were inversely associated with the severity of freezing of gait. The lateralization of these effective connectivity patterns was not attributable to the initial dopaminergic deficit nor to structural changes in these regions.Conclusions: We have identified novel effective connectivity and an independent self‐inhibitory connectivity underlying freezing of gait. Our findings imply that modulating the effective connectivity between the left DLPFC and MLR through neurostimulation or other interventions could be a target for reducing freezing of gait in PD. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

1 October 2025 in Neurology Clinical Practice
Verified
Journal Article
Open access
LGLindun Ge
Lindun Ge
YKYasuyoshi Kimura
Yasuyoshi Kimura
KKKeita Kakuda
Keita Kakuda
KOKotaro Ogawa
Kotaro Ogawa
YKYuta Kajiyama
Yuta Kajiyama
HMHideki Mochizuki
Hideki Mochizuki
Atypical psychosis, characterized by severe delusions, paranoia, and auditory or somatic hallucinations, is a notable complication of continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa therapy in Parkinson disease (PD). The aim of this study was to identify clinical predictors of CSCI-induced psychosis to understand its potential mechanisms and evaluate predictive measures for early detection and management. This retrospective cohort study included patients with PD treated with CSCI (n = 23) and an independent PD database cohort (n = 94) from Osaka University Hospital. In the CSCI cohort, clinical data such as psychosis information and answers from Parkinson's Disease Questionnaire (PDQ39) and the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease–Current Symptoms (QUIP-CS) were collected. Statistical analyses included independent t tests and linear regression to identify predictors of atypical psychosis within a year of CSCI initiation. In the PD database cohort, potential relationships between QUIP-CS scores and other clinical parameters were explored using correlational analyses. Among the 23 patients, 6 developed atypical psychosis, all occurring within 6 months, with 4 of them discontinuing CSCI. Patients who developed atypical psychosis had significantly higher QUIP-CS scores before CSCI (adjusted p = 0.0032). Linear regression identified QUIP-CS as the sole predictor of atypical psychosis onset (coefficient = 0.199, p < 0.001). Among the PDQ39 subitems, item 27 showed a significant correlation with QUIP-CS scores (r = 0.722, adjusted p = 0.0128). Furthermore, a composite score comprising PDQ39 items 20, 27, 29, 31, and 36 (PDQ39_sub5) showed an even stronger correlation with QUIP-CS scores (r = 0.770, p = 0.0000704). This association was independently confirmed in the PD database cohort (r = 0.415, p = 0.00003). Finally, PDQ39_sub5 effectively stratified survival curves for psychosis onset in the CSCI cohort (p = 0.008). CSCI-induced psychosis is distinct from visual hallucinations observed in typical PD psychosis and likely involves mechanisms in mesolimbic circuits and impulsive-compulsive behaviors associated with dopamine dysregulation. While QUIP-CS is rarely used in clinical practice, widely used PDQ39_sub5 offers a practical way to identify individual psychosis risk. These findings potentially offer tailored strategies to predict and manage atypical psychosis in patients with PD receiving advanced dopaminergic therapies.

7 October 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
TKTakaya Kitano
Takaya Kitano
TSTsutomu Sasaki
Tsutomu Sasaki
TMTakahiro Matsui
Takahiro Matsui
MKMasaharu Kohara
Masaharu Kohara
KOKotaro Ogawa
Kotaro Ogawa
HMHideki Mochizuki
Hideki Mochizuki
Background: Thrombi follow various natural courses. They are known to become harder over time and may persist long term; some of them can also undergo early spontaneous dissolution and disappearance. Hindering thrombus stability may contribute to the treatment of thrombosis and the prevention of embolisms. However, the detailed mechanisms underlying thrombus maturation remain unclear. Methods: We compared the RNA expression in 3 thrombi retrieved from cerebral vessels via thrombectomy with that in simultaneously sampled blood. The results were validated using immunohistochemistry on 66 thrombi retrieved from patients with cerebral embolism. Single‐cell RNA sequencing data of thrombi from pulmonary arteries were used to uncover the molecular mechanisms. Results: A total of 1121 genes were upregulated in thrombi. Pathway enrichment and protein–protein interaction analyses revealed upregulation of extracellular matrix formation and identified SPP1 as a hub gene. Immunohistochemistry revealed that expression level of osteopontin (the transcript of SPP1 ) positively correlated to that of collagen type VI in thrombi. Osteopontin was expressed primarily by monocytes/macrophages in the thrombi, particularly in older ones. Among these 66 patients, the presence of collagen type VI in the thrombus was marginally associated with longer puncture‐to‐reperfusion time and more passes before reperfusion, indicating that those thrombi were resistant to thrombectomy. Single‐cell RNA sequencing of thrombi identified a subpopulation of monocytes/macrophages that highly express SPP1 . These SPP1 ‐high monocytes/macrophages highly expressed genes related to the extracellular matrix and communicated closely with fibroblasts. Conclusions: Collectively, our findings indicate that SPP1 ‐high monocytes/macrophages play a crucial role in thrombus maturation.

9 March 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KOKotaro Ogawa
Kotaro Ogawa
LTLam Tsoi
Lam Tsoi
HTHiroaki Tanaka
Hiroaki Tanaka
MKMasahiro Kanai
Masahiro Kanai
PSPhilip E. Stuart
Philip E. Stuart
YOYukinori Okada
Yukinori Okada

1 November 2025 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
SMShumpei Murakami
Shumpei Murakami
KKKeigo Kihrara
Keigo Kihrara
KOKotaro Ogawa
Kotaro Ogawa
HMHideki Mochizuki
Hideki Mochizuki